Produktbild: Phytochemicals in Urological Cancers
Neu

Phytochemicals in Urological Cancers From Pathophysiology to Preclinical and Translational Advances

213,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

06.07.2026

Abbildungen

XX, 46 illus., 21 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Hardeep Singh Tuli + weitere

Verlag

Springer Singapore

Seitenzahl

246

Maße (L/B)

23,5/15,5 cm

Sprache

Englisch

ISBN

978-981-9211-57-9

Beschreibung

Portrait

Dr. Hardeep Singh Tuli is a Professor at the Department of Bio-Sciences & Technology, Maharishi Markandeshwar (Deemed to be University), Mullana, India. He previously served as a Lecturer at the Department of Applied Sciences, Institute of Science and Technology, Klawad, Yamunanagar (2009-2011), India. His research interests are focused on the isolation, characterization, and biochemical evaluation of natural metabolites as anticancer agents. He has served as a reviewer for several international journals and as an editor/ guest editor for various SCI-indexed journals. He has more than 15 years of teaching and research experience in pharmacology, mammalian physiology, and natural products. He has published more than 350 papers in peer-reviewed- reviewed international journals and authored several book chapters. He has 12,600+ citations and an h-index of 56. He edited 10 International books in the area of natural products, chemoprevention, and nanoformulations. In addition, Dr. Tuli is listed in the World Top 2% Scientists, 2021, 2022, 2023, 2024 & 2025.

Dr. Shafiul Haque is a Professor of Microbiology and Molecular Genetics at the College of Nursing and Health Sciences, Jazan University, Saudi Arabia. He received his B.Sc. and M.Sc. in Biology from DDU Gorakhpur University, and his M.Tech and PhD in Biotechnology from Dr. APJ Abdul Kalam Technical University and Jamia Millia Islamia, India, respectively. He also holds an MBA and has training in regulatory affairs and Intellectual Property Rights. Dr. Haque previously worked at Bio-Rad Laboratories Inc. as an Application Specialist/Scientist for the EMEA region and West India and completed Postdoctoral research at the University of Helsinki, Finland, focusing on novel antibiotics from natural products. He also served as a Research Consultant at King Khalid University Hospital, King Saud University, Riyadh. He has published over 500 peer-reviewed research articles, contributed to several international book chapters, and serves on the editorial boards of multiple scientific journals. His research focuses on molecular genetics, antimicrobial resistance, natural products, bioinformatics, and AI-driven approaches in healthcare research, with particular emphasis on discovering novel therapeutics and understanding microbial resistance mechanisms.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

06.07.2026

Abbildungen

XX, 46 illus., 21 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen

Herausgeber

Verlag

Springer Singapore

Seitenzahl

246

Maße (L/B)

23,5/15,5 cm

Sprache

Englisch

ISBN

978-981-9211-57-9

Herstelleradresse

Springer Singapore
No. 12-2F 101 Business Park
47100 Puchong, Selangor D.E.
MY
Email: sdc-bookservice@springer.com
Telephone: +49 6221 3454301
Fax: +49 6221 3454229

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Phytochemicals in Urological Cancers
  • Chapter 1. Epidemiology, risk factors and global statistics of various Urological cancers.- Chapter 2. The role of tumor microenvironment in urological cancers pathophysiology.- Chapter 3. Recent Advances in Detection and Diagnosis of Urological Cancers.- Chapter 4. Anticancer Phytochemicals in Bladder Cancer.- Chapter 5. Evolving recent paradigm in chemoprevention of kidney cancer.- Chapter 6. Anti-proliferative natural metabolites to inhibit penis and testicle tumor.- Chapter 7. Challenges and Emerging Therapeutic Approaches in Prostate Cancer.- Chapter 8. Nanotechnology Mediated Targeted Delivery of Phytochemicals in Urological Cancers.- Chapter 9. Interplay Between IncRNA and Phytochemicals in Urological Cancers.- Chapter 10. Regulatory Perspectives for Phytochemicals and Their Clinical Translation. Chapter 11. Current State of Clinical Trials in Urological Cancers and Future Directions.